GIM
RVMD icon

Granahan Investment Management’s Revolution Medicines RVMD Stock Holding History

Granahan Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,573
Closed -$4.14M – 162
2026
Q1 		$4.14M Sell
42,573
-56,621
-57% -$5.72M 0.2% 112
2025
Q4 		$7.9M Sell
99,194
-19,498
-16% -$1.28M 0.34% 70
2025
Q3 		$5.54M Sell
118,692
-3,088
-3% -$121K 0.23% 89
2025
Q2 		$4.48M Sell
121,780
-4,972
-4% -$191K 0.18% 106
2025
Q1 		$4.48M Buy
126,752
+7,322
+6% +$297K 0.22% 100
2024
Q4 		$5.22M Sell
119,430
-29,929
-20% -$1.51M 0.22% 104
2024
Q3 		$6.77M Buy
+149,359
New +$6.5M 0.27% 104

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Granahan Investment Management's RVMD Position: Q2 2026 in Review

Granahan Investment Management sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 42,573 shares — an estimated $4.14M sold.

Granahan Investment Management first reported a position in RVMD in Q3 2024 and held it in 7 quarters. The position peaked at $7.9M in Q4 2025. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Granahan Investment Management reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Granahan Investment Management sold 42,573 Revolution Medicines shares in Q2 2026, an estimated $4.14M.
  • Granahan Investment Management first reported a position in Revolution Medicines in Q3 2024 and held it in 7 quarters.
  • Granahan Investment Management's Revolution Medicines position peaked at $7.9M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.